晨光生物(300138) - 2023年10月24日投资者关系活动记录表
CCGBCCGB(SZ:300138)2023-10-24 11:44

Group 1: Financial Performance - In the first three quarters of 2023, the company achieved operating revenue of 5.169 billion yuan, a year-on-year increase of 7.78% [1] - In Q3 2023, the operating revenue was 1.501 billion yuan, a decrease of approximately 4.36% year-on-year [1] - Net profit attributable to shareholders for the first three quarters was 398 million yuan, a year-on-year increase of 18.29% [2] - Q3 net profit attributable to shareholders was 99.97 million yuan, a year-on-year increase of 3.46% [2] Group 2: Business Segment Performance - Revenue from plant extraction business in Q3 was 646 million yuan, a year-on-year increase of approximately 2% [1] - Revenue from cottonseed business in Q3 was 789 million yuan, a year-on-year decrease of approximately 11% [1] - Sales volume of chili red pigment increased by 15% year-on-year, while chili extract sales volume grew by 18% [2] - Sales volume of feed-grade lutein decreased by approximately 60% year-on-year, while food-grade lutein sales volume increased by approximately 70% [2] Group 3: Market and Product Development - The company is actively developing differentiated and customized products to enhance customer problem-solving capabilities and increase product added value [2] - The health food business achieved sales exceeding 100 million yuan, a year-on-year increase of over 70% [2] - The company is expanding its raw material base, with significant growth in planting areas for marigold in India and Zambia [3] Group 4: Seasonal Trends and Future Outlook - Cottonseed business typically sees concentrated procurement of raw materials in Q4 and Q1 of the following year [4] - The company plans to launch new projects in the cottonseed business in Q4, with production gradually ramping up to design capacity [3] - The health food business is expected to maintain an upward trend in profit margins due to improved customer structure and scale effects [5]